In briefBMJ 2014; 348 doi: http://dx.doi.org/10.1136/bmj.g334 (Published 17 January 2014) Cite this as: BMJ 2014;348:g334
A story in this “In brief” column of the News section (BMJ 2014;348:g210, doi:10.1136/bmj.g210) has an incorrect headline. The item pointed out that the European Medicines Agency has recommended that strontium ranelate (marketed by Servier as Protelos) no longer be used to treat osteoporosis, but its headline said “Osteoporosis drug is suspended in Europe.” The headline should have read “European Medical Association recommends suspension of osteoporosis drug in Europe” because the recommendation by the agency’s Pharmacovigilance Risk Assessment Committee (PRAC) has not yet been endorsed by the agency’s Committee for Medicinal Products for Human Use (CHMP). The CHMP is expected to issue the agency’s final opinion at its meeting of 20 to 23 January 2014.
Cite this as: BMJ 2014;348:g334